scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...9k3722T |
P356 | DOI | 10.1371/JOURNAL.PONE.0113722 |
P932 | PMC publication ID | 4237509 |
P698 | PubMed publication ID | 25409436 |
P5875 | ResearchGate publication ID | 268787564 |
P2093 | author name string | Makoto Makishima | |
Hiromichi Takahashi | |||
Jin Takeuchi | |||
Masaru Nakagawa | |||
Noriyoshi Iriyama | |||
Yoshihiro Hatta | |||
Masami Takei | |||
Hikaru Uchida | |||
Yuichiro Hasegawa | |||
P2860 | cites work | Regulation of adaptive immunity; the role of interleukin-10 | Q21131215 |
Noncalcemic Actions of Vitamin D Receptor Ligands | Q22306219 | ||
Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids | Q24563907 | ||
Exploring the full spectrum of macrophage activation | Q24653754 | ||
Nuclear Receptors, RXR, and the Big Bang | Q26821789 | ||
The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
Novel synthetic retinoids and separation of the pleiotropic retinoidal activities | Q34595199 | ||
Acute promyelocytic leukemia: from highly fatal to highly curable | Q34755208 | ||
Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice | Q34790753 | ||
Primary vitamin D target genes allow a categorization of possible benefits of vitamin D₃ supplementation | Q34907819 | ||
Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3 | Q35462970 | ||
1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells | Q36209927 | ||
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid | Q36390529 | ||
Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment | Q36745391 | ||
Vitamin A and retinoid signaling: genomic and nongenomic effects | Q36920549 | ||
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells | Q37600754 | ||
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure | Q37802188 | ||
Vitamin D and immune function: an overview | Q37919185 | ||
Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response | Q38005670 | ||
Molecular mechanisms of vitamin D action | Q38025329 | ||
Tumor-associated macrophages: from mechanisms to therapy | Q38230880 | ||
Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors | Q39130992 | ||
Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A. | Q39286958 | ||
Primary effect of 1α,25(OH)₂D₃ on IL-10 expression in monocytes is short-term down-regulation | Q39670347 | ||
Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia | Q39700405 | ||
Role of nitric oxide in the anti-tumoral effect of retinoic acid and 1,25-dihydroxyvitamin D3 on human promonocytic leukemic cells | Q41155719 | ||
All-trans and 9-cis retinoic acid enhance 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells | Q41177274 | ||
All-trans retinoic acid and 1 alpha,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes | Q41469268 | ||
Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. | Q41483379 | ||
Effect of retinoic acid and vitamin D on the expression of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 in the human monocytic cell line U937. | Q41550703 | ||
Synergistic effect of retinoic acid and 1,25-dihydroxyvitamin D3 on the differentiation of the human monocytic cell line U937. | Q41705909 | ||
Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity | Q42210175 | ||
The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1alpha,25(OH)2D3 target genes | Q43126154 | ||
Structural determinants of allosteric ligand activation in RXR heterodimers. | Q44796708 | ||
Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells. | Q46017703 | ||
A micromethod for the isolation of total RNA from adipose tissue. | Q46147595 | ||
Retinoic acid signaling is essential for embryonic hematopoietic stem cell development | Q46331596 | ||
1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells | Q46465299 | ||
1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation | Q46665943 | ||
Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages. | Q54560299 | ||
Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways | Q57278895 | ||
Combined vitamin D3/retinoic acid induction of human promyelocytic cell lines: enhanced phagocytic cell maturation and hybrid granulomonocytic phenotype | Q57616779 | ||
Regulation of Retinoidal Actions by Diazepinylbenzoic Acids.1Retinoid Synergists Which Activate the RXR−RAR Heterodimers | Q61818639 | ||
HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3 | Q68518557 | ||
Expression of tissue transglutaminase in cultured monocytic leukemia (THP-1) cells during differentiation | Q69875572 | ||
9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro | Q70548117 | ||
Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60 | Q70897371 | ||
Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid | Q71010600 | ||
Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids | Q71985393 | ||
Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis | Q72618171 | ||
1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes | Q72645049 | ||
Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing agents | Q72939434 | ||
Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid | Q73555297 | ||
Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells | Q78024359 | ||
Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery | Q79346307 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tretinoin | Q29417 |
P304 | page(s) | e113722 | |
P577 | publication date | 2014-11-19 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3 | |
P478 | volume | 9 |